INS and metabolic disease: Although such association was observed with indices representing insulin secretion in a fasting condition, not with those representing glucose–stimulated insulin secretion, these results may inform further studies including those on how to best identify patients suitable for GC suppression therapies for metabolic disorders including diabetes.